Dumond H, Presle N, Pottie P, Pacquelet S, Terlain B, Netter P, Gepstein A, Livne E, Jouzeau J-Y
Laboratoire de Pharmacologie et Physiopathologie articulaires, UMR CNRS-UHP 7561, Faculté de Médecine, Avenue de la Forêt de Haye, BP 184, 54505 Vandoeuvre-lès-Nancy, France.
Osteoarthritis Cartilage. 2004 Apr;12(4):284-95. doi: 10.1016/j.joca.2003.11.008.
To characterize the molecular events underlying cartilage injury in the early phase of mono-iodoacetate-induced osteoarthritis (OA) in rats.
Experimental osteoarthritis was induced by intra-articular injection of 0.03mg mono-iodoacetate (MIA) in Wistar rats. Animals were killed 2, 5, 10, 15 and 20 days post-injection. Synovial tissue and standardized biopsies from different areas of knee cartilage were examined. Proteoglycan synthesis ((35)S incorporation) and gelatinase activities (zymography), semi-quantitative RT-PCR and immunohistochemistry for IL1beta, iNOS, COX2 and PPARgamma, were performed on these samples.
Changes in proteoglycan synthesis and gelatinase activities were time and site-dependent. Proteoglycan synthesis inhibition was maximal by day 2 while the highest gelatinase activities were observed at day 5. Central part of patella and posterior plateaus and condyles, i.e. the weight-bearing cartilage areas, were the most affected. IL1beta and iNOS transcripts were induced early in cartilage at time of maximal proteoglycan synthesis inhibition, especially in weight-bearing areas. COX-2 was slightly up-regulated whereas PPARgamma gene expression remained unchanged. Gene expression profile in synovium paralleled that of cartilage, except for PPARgamma which was up-regulated at day 15 and 20. Immunostaining for IL1beta and iNOS showed that proteins were located in diseased cartilage areas at early stage of the experimental OA (day 2). At later time-points (day 20), IL1beta and iNOS were expressed in perilesional areas whereas immunostaining became below control level for COX-2 and PPARgamma.
Time-dependent degradation of cartilage after injection of low dose of MIA (0.03mg) into rat knee joint can be related to early loss of proteoglycan anabolism, increased gelatinase activities and expression of IL1beta and downstream inflammatory genes. Increased susceptibility to MIA in weight-bearing areas of cartilage further indicate that MIA-induced experimental OA is a relevant model to study not only metabolical but also biomechanical aspects of human OA.
描述大鼠单碘乙酸诱导的骨关节炎(OA)早期软骨损伤背后的分子事件。
通过向Wistar大鼠关节腔内注射0.03mg单碘乙酸(MIA)诱导实验性骨关节炎。在注射后2、5、10、15和20天处死动物。检查滑膜组织以及来自膝关节软骨不同区域的标准化活检样本。对这些样本进行蛋白聚糖合成(³⁵S掺入)和明胶酶活性(酶谱分析)、半定量逆转录聚合酶链反应(RT-PCR)以及针对白细胞介素1β(IL1β)、诱导型一氧化氮合酶(iNOS)、环氧化酶2(COX2)和过氧化物酶体增殖物激活受体γ(PPARγ)的免疫组织化学检测。
蛋白聚糖合成和明胶酶活性的变化具有时间和部位依赖性。蛋白聚糖合成抑制在第2天达到最大程度,而最高的明胶酶活性在第5天观察到。髌骨中央部分以及后平台和髁,即负重软骨区域,受影响最大。在蛋白聚糖合成抑制最大时,软骨中IL1β和iNOS转录本早期被诱导,尤其是在负重区域。COX-2略有上调,而PPARγ基因表达保持不变。滑膜中的基因表达谱与软骨相似,但PPARγ在第15天和20天上调。对IL1β和iNOS的免疫染色显示,在实验性OA早期(第2天),蛋白质位于病变软骨区域。在后期时间点(第20天),IL1β和iNOS在损伤周围区域表达,而COX-2和PPARγ的免疫染色低于对照水平。
向大鼠膝关节注射低剂量MIA(0.03mg)后,软骨的时间依赖性降解可能与蛋白聚糖合成代谢的早期丧失、明胶酶活性增加以及IL1β和下游炎症基因的表达有关。软骨负重区域对MIA的易感性增加进一步表明,MIA诱导的实验性OA不仅是研究人类OA代谢方面,也是研究其生物力学方面的相关模型。